This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a York University directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Effects of the adiponectin mimetic compound ALY688 on glucose and fat metabolism in visceral and subcutaneous rat adipocytes.
Adipocyte · 2020
Latest funding
- $180,275
Enabling precision medicine in type 1 diabetes (T1D): leveraging integrative multiomics to understand T1D endotypes for therapy
CIHR · 2023 · Nominated PI
1 publications.
Effects of the adiponectin mimetic compound ALY688 on glucose and fat metabolism in visceral and subcutaneous rat adipocytes.
Da Eira D, Jani S, Sung H, Sweeney G, Ceddia RB
Enabling precision medicine in type 1 diabetes (T1D): leveraging integrative multiomics to understand T1D endotypes for therapy
Principal investigators: Sung, Hyekyoung
Keywords: Adiponectin; Beta Cell; Innate Immunity; Insulin; Microbiome; Regulatory T Cell (Treg); Type 1 Diabetes (T1d)
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.